Montelukast Sodium Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

How Will the Montelukast Sodium Market Grow, and What Is the Projected Market Size?
There has been considerable growth in the montelukast sodium market size over the last few years. A hike from $3.86 billion in 2024 to $4.24 billion in 2025 is predicted, corresponding to a compound annual growth rate (CAGR) of 9.9%. Several factors contribute to this historical growth trend, including a surge in respiratory ailments, an older population demographic, escalating air pollution rates, broader awareness and educational efforts, and growth in burgeoning markets.

The market size of montelukast sodium is predicted to experience significant expansion in the upcoming years. The market is set to reach $6.12 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.6%. Factors contributing to the growth during the forecast period include approval and launch of the product, clinical trials, patent expiration, changes in regulations, and prescribing behaviors of physicians. Key trends forecasted for this period encompass the rise of generic competition, a tilt toward combination therapies, development in burgeoning markets, emphasis on pediatric application, and the incorporation of digital health solutions.

What Are the Forces Behind the Rapid Growth of the Montelukast Sodium Market?
The growing rate of asthma is predicted to boost the development of the montelukast sodium market. Asthma, a long-lasting respiratory disease characterized by airway inflammation and narrowing, leads to recurring episodes of wheezing, breathlessness, tightness in the chest, and coughing. Factors such as environmental pollution, exposure to allergens, genetic susceptibility, urbanization, lifestyle modifications, and respiratory infections are causing an increase in the incidence of asthma. Montelukast sodium acts as a leukotriene receptor antagonist in asthma, aiding with the prevention and management of asthma symptoms by inhibiting leukotrienes which play a part in airway inflammation and narrowing. For example, according to information released in July 2024 by the American Lung Association, a health organization based in the US, around 44.2 million Americans, or 13.5% of the population, were diagnosed with asthma by a healthcare professional in 2022. Thus, the escalating rate of asthma is stimulating the expansion of the montelukast sodium market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp

Who Are the Major Industry Players Fueling Montelukast Sodium Market Expansion?
Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd

Which Key Developments Are Influencing the Montelukast Sodium Market?
Leading firms in the montelukast sodium market are innovating with new pharmaceutical products such as over-the-counter generic drugs to expand treatment alternatives for those suffering from asthma and allergic rhinitis. Over-the-counter (OTC) generic medicines do not require a prescription and are typically sold in pharmacies or local retail outlets. For example, Dr. Reddy's Laboratories, a pharmaceutical company headquartered in India, unveiled Fexofenadine HCL 180 mg and Pseudoephedrine HCl 240 mg in the US in July 2022. This drug is intended to provide temporary relief from nasal and sinus congestion caused by colds or allergies. Comparable to Allegra-D 24 HR, it fuses an antihistamine and a nasal decongestant to mitigate symptoms like sneezing, runny nose, eye itchiness, and throat irritation. It comes in packs of 5, 10, and 15, providing a premium, affordable solution for individuals seeking relief from upper respiratory discomfort.

How Is the Segmentation of the Montelukast Sodium Market Defined?
The montelukast sodium market covered in this report is segmented -

1) By Product: Crystal-like, Form-less Or Amorphous
2) By Dosage Form: Tablets, Oral Solutions
3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications

Subsegments:
1) By Crystal-Like: Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium
2) By Form-Less Or Amorphous: Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

What Is the Leading Region in the Montelukast Sodium Market?
North America was the largest region in the montelukast sodium market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Montelukast Sodium Global Market Report?

- Market Size Analysis: Analyze the Montelukast Sodium Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Montelukast Sodium Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Montelukast Sodium Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Montelukast Sodium Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16123

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.